MedTrace Logo

Cognition and Ultrasound

NCT07220655 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-10-24

No results posted yet for this study

Summary

Our primary goal is to investigate the role of Low-Intensity Focused Ultrasound (LIFU) neuromodulation on deep brain targets, and its potential to improve cognition

Conditions

  • Healthy Participants

Interventions

DEVICE

Low-Intensity Focused Ultrasound (FUS or LIFU)

We will use an established, currently-marketed device to deliver LIFU neuromodulation.

Sponsors & Collaborators

Principal Investigators

  • Michael Bronstein · University of Minnesota

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2028-07-01
Completion
2028-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07220655 on ClinicalTrials.gov